
APOPTOSIS GENE EXPRESSION PROFILE IN
EARLY-STAGE NON SMALL CELL LUNG CANCER Metodieva SN1, Cherneva RV, Nikolova DN,
Genchev GD, Petrov DB, Toncheva DI *Corresponding Author: Svetlana Nikolova Metodieva, Department of Medical Genetics,
Medical University Sofia, 2 Zdrave str, 1431 Sofia, Bulgaria; Tel.: +359-2-952-0357; Fax: +359-
2-952-0357; E-mail: svetlana.metodieva@yahoo.com page: 47
|
REFERENCES
1. Ferlay J, Parkin DM, Steliarova-Foucher
E. Estimates of cancer incidence and mortality in
Europe in 2008. Eur J Cancer. 2010; 46(4): 765-
781.
2. Lung cancer incidence and mortality
worldwide in 2008. Summary. (http://globocan.iarc.
fr/factsheets/cancers/ lung.asp).
3. Lonardo F, Li X, Kaplun A, Soubani A,
Sethi S, Gadgeel S, Sheng S. The natural tumor
suppressor protein maspin and potential application
in non small cell lung cancer. Curr Pharm Des.
2010; 16(16): 1877-1881.
4. Sculier JP, Chansky K, Crowley JJ, Van
Meerbeeck J, Goldstraw P; International Staging
Committee and Participating Institutions. The
impact of additional prognostic factors on survival
and their relationship with the anatomical extent
of disease expressed by the 6th Edition of the
TNM Classification of Malignant Tumors and the
proposals for the 7th Edition. J Thorac Oncol. 2008;
3(5): 457-466.
5. Valerianova ZG, Vukov MI, Dimitrova NE,
Eds. Cancer Incidence in Bulgaria 2006, 1st ed.
Sofia: AVIS-24 Ltd, 2008.
6. Zochbauer-Muller S, Gazdar AF, Minna JD.
Molecular pathogenesis of lung cancer. Annu Rev
Physiol. 2002; 64: 681-708.
7. Pignon JP, Tribodet H, Scagliotti GV,
Douillard JY, Shepherd FA, Stephens RJ, Dunant A,
Torri V, Rosell R, Seymour L, Spiro SG, Rolland
E, Fossati R, Aubert D, Ding K, Waller D, Le
Chevalier T; LACE Collaborative Group. Lung
adjuvant cisplatin evaluation: a pooled analysis by
the LACE Collaborative Group. J Clin Oncol. 2008;
26(21): 3552-3559.
8. Goldstraw P, Crowley J, Chansky K, Giroux
DJ, Groome PA, Rami-Porta R, Postmus PE, Rusch
V, Sobin L; International Association for the Study
of Lung Cancer International Staging Committee;
Participating Institutions. The IASLC Lung Cancer
Staging Project: proposals for the revision of the
TNM stage groupings in the forthcoming (seventh)
edition of the TNM classification of malignant
tumours. J Thorac Oncol. 2007; 2(8): 706–714.
9. Fulda S. Tumor resistance to apoptosis. Int J
Cancer. 2009; 124(3): 511-515.
10. Horn L, Sandler A. Epidermal growth factor
receptor inhibitors and antiangiogenic agents for the
treatment of non-small cell lung cancer. Clin Cancer
Res. 2009; 15(16): 5040-5048.
11. Schulz WA. Apoptosis and replicative
senescence in cancer. In: Schulz WA, Ed. Molecular
Biology of Human Cancers. Dordrecht: Springer
Science + Business Media. 2005: 145.
12. Kang BN, Ahmad AS, Saleem S, Patterson
RL, Hester L, Doré S, Snyder SH. Death-associated
protein kinase-mediated cell death modulated by
interaction with DANGER. J Neurosci. 2010; 30(1):
93-98.
13. Jang CW, Chen CH, Chen CC, Chen J, Su
YH, Chen RH. TGF-beta induces apoptosis through
Smad-mediated expression of DAP-kinase. Nature
Cell Biol. 2001; 4(1): 51-58.
14. Mashkova TD, Oparina NIu, Zinov’eva OL,
Kropotova ES, Dubovaia VI, Poltaraus AB, Fridman
MV, Kopantsev EP, Vinogradova TV, Zinov’eva
MV, Laktionov KK, Kasymova OT, Zborovskaia
IB, Sverdlov ED, Kiselev LL. Transcription TIMP3,
DAPk1 and AKR1B10 genes in squamous cell lung
cancer. Mol Biol (Mosk). 2006; 40(6): 1047-1054.
15. Han W, Wang T, Reilly AA, Keller SM,
Spivack SD. Gene promoter methylation assayed
in exhaled breath, with differences in smokers and
lung cancer patients. Respir Res. 2009; 10: 86.
16. Wang Y, Zhang D, Zheng W, Luo J, Bai Y, Lu
Z. Multiple gene methylation of nonsmall cell lung
cancers evaluated with 3-dimensional microarray.
Cancer. 2008; 112(6): 1325-1336.
17. Liu Y, Gao W, Siegfried JM, Weissfeld JL,
Luketich JD, Keohavong P. Promoter methylation
of RASSF1A and DAPK and mutations of K-ras, p53, and EGFR in lung tumors from smokers and
never-smokers. BMC Cancer. 2007; 7: 74.
18. Logue SE, Martin SJ. Caspase activation
cascades in apoptosis. Biochem Soc Trans. 2008;
36(Pt. 1): 1-9.
19. Neumann L, Pforr C, Beaudouin J, Pappa
A, Fricker N, Krammer PH, Lavrik IN, Eils
R. Dynamics within the CD95 death-inducing
signaling complex decide life and death of cells.
Mol Syst Biol. 2010; 6: 352.
20. Yang Q, Kiernan CM, Tian Y, Salwen HR,
Chlenski A, Brumback BA, London WB, Cohn
SL. Methylation of CASP8, DCR2, and HIN-1 in
neuroblastoma is associated with poor outcome.
Clin Cancer Res. 2007; 13(11): 3191-3197.
21. Stupack DG, Teitz T, Potter MD, Mikolon
D, Houghton PJ, Kidd VJ, Lahti JM, Cheresh
DA. Potentiation of neuroblastoma metastasis by
loss of caspase-8. Nature. 2006; 439(7072): 95-
99.
22. Su H, Bidere N, Zheng L, Cubre A, Sakai
K, Dale J, Salmena L, Hakem R, Straus S, Lenardo
M. Requirement for caspase-8 in NF-kappa-B
activation by antigen receptor. Science. 2005;
307(5714): 1465-1468.
23. Bae J, Leo CP, Hsu SY, Hsueh AJW. MCL-
1S, a splicing variant of the antiapoptotic BCL-2
family member MCL-1, encodes a proapoptotic
protein possessing only the BH3 domain. J Biol
Chem. 2000; 275(33): 25255-25261.
|
|
|
|



 |
Number 25 VOL. 25 (1), 2022 |
Number 24 VOL. 24(2), 2021 |
Number 24 VOL. 24(1), 2021 |
Number 23 VOL. 23(2), 2020 |
Number 22 VOL. 22(2), 2019 |
Number 22 VOL. 22(1), 2019 |
Number 22 VOL. 22, 2019 Supplement |
Number 21 VOL. 21(2), 2018 |
Number 21 VOL. 21 (1), 2018 |
Number 21 VOL. 21, 2018 Supplement |
Number 20 VOL. 20 (2), 2017 |
Number 20 VOL. 20 (1), 2017 |
Number 19 VOL. 19 (2), 2016 |
Number 19 VOL. 19 (1), 2016 |
Number 18 VOL. 18 (2), 2015 |
Number 18 VOL. 18 (1), 2015 |
Number 17 VOL. 17 (2), 2014 |
Number 17 VOL. 17 (1), 2014 |
Number 16 VOL. 16 (2), 2013 |
Number 16 VOL. 16 (1), 2013 |
Number 15 VOL. 15 (2), 2012 |
Number 15 VOL. 15, 2012 Supplement |
Number 15 Vol. 15 (1), 2012 |
Number 14 14 - Vol. 14 (2), 2011 |
Number 14 The 9th Balkan Congress of Medical Genetics |
Number 14 14 - Vol. 14 (1), 2011 |
Number 13 Vol. 13 (2), 2010 |
Number 13 Vol.13 (1), 2010 |
Number 12 Vol.12 (2), 2009 |
Number 12 Vol.12 (1), 2009 |
Number 11 Vol.11 (2),2008 |
Number 11 Vol.11 (1),2008 |
Number 10 Vol.10 (2), 2007 |
Number 10 10 (1),2007 |
Number 9 1&2, 2006 |
Number 9 3&4, 2006 |
Number 8 1&2, 2005 |
Number 8 3&4, 2004 |
Number 7 1&2, 2004 |
Number 6 3&4, 2003 |
Number 6 1&2, 2003 |
Number 5 3&4, 2002 |
Number 5 1&2, 2002 |
Number 4 Vol.3 (4), 2000 |
Number 4 Vol.2 (4), 1999 |
Number 4 Vol.1 (4), 1998 |
Number 4 3&4, 2001 |
Number 4 1&2, 2001 |
Number 3 Vol.3 (3), 2000 |
Number 3 Vol.2 (3), 1999 |
Number 3 Vol.1 (3), 1998 |
Number 2 Vol.3(2), 2000 |
Number 2 Vol.1 (2), 1998 |
Number 2 Vol.2 (2), 1999 |
Number 1 Vol.3 (1), 2000 |
Number 1 Vol.2 (1), 1999 |
Number 1 Vol.1 (1), 1998 |
|
|
|